These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25592234)

  • 21. Cisplatin-induced ototoxicity in pediatric solid tumors: the role of glutathione S-transferases and megalin genetic polymorphisms.
    Choeyprasert W; Sawangpanich R; Lertsukprasert K; Udomsubpayakul U; Songdej D; Unurathapan U; Pakakasama S; Hongeng S
    J Pediatr Hematol Oncol; 2013 May; 35(4):e138-43. PubMed ID: 23274376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
    Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
    Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
    Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
    Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.
    Liu ZF; Asila AL; Aikenmu K; Zhao J; Meng QC; Fang R
    Genet Mol Res; 2015 Oct; 14(4):12967-72. PubMed ID: 26505449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
    Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
    Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
    García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
    Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.
    Oldenburg J; Kraggerud SM; Brydøy M; Cvancarova M; Lothe RA; Fossa SD
    J Transl Med; 2007 Dec; 5():70. PubMed ID: 18162130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.
    Lecomte T; Landi B; Beaune P; Laurent-Puig P; Loriot MA
    Clin Cancer Res; 2006 May; 12(10):3050-6. PubMed ID: 16707601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.
    Holley SL; Rajagopal R; Hoban PR; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
    Int J Oncol; 2006 Jan; 28(1):231-6. PubMed ID: 16328000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: a case-control study in a Turkish population.
    Gönül N; Kadioglu E; Kocabaş NA; Ozkaya M; Karakaya AE; Karahalil B
    Gene; 2012 Aug; 505(1):121-7. PubMed ID: 22652274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies.
    Dusinska M; Staruchova M; Horska A; Smolkova B; Collins A; Bonassi S; Volkovova K
    Mutat Res; 2012 Aug; 736(1-2):130-7. PubMed ID: 22450146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of GSTM1, GSTT1, GSTP1 and TP53 disease-associated gene variants in native and urban Venezuelan populations.
    Chiurillo MA; Griman P; Santiago L; Torres K; Moran Y; Borjas L
    Gene; 2013 Nov; 531(1):106-11. PubMed ID: 23994684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.
    Ibarrola-Villava M; Martin-Gonzalez M; Lazaro P; Pizarro A; Lluch A; Ribas G
    Br J Dermatol; 2012 Jun; 166(6):1176-83. PubMed ID: 22251241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
    Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
    Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of glutathione S-transferase genetic variants affecting type 2 diabetes susceptibility: a meta-analysis.
    Tang ST; Wang CJ; Tang HQ; Zhang Q; Wang Y
    Gene; 2013 Nov; 530(2):301-8. PubMed ID: 24008019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemia.
    Borst L; Buchard A; Rosthøj S; Wesolowska A; Wehner PS; Wesenberg F; Dalhoff K; Schmiegelow K
    J Pediatr Hematol Oncol; 2012 Jan; 34(1):38-42. PubMed ID: 22215096
    [TBL] [Abstract][Full Text] [Related]  

  • 40.  GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.
    Oliveira AL; Oliveira Rodrigues FF; Dos Santos RE; Rozenowicz RL; Barbosa de Melo M
    Genet Mol Res; 2014 Jan; 13(2):2521-30. PubMed ID: 24535908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.